Nevena Ilieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nevena Ilieva has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Elena Lilkova
Institute of Information and Communication Technologies, Bulgarian Academy of Sciences
30 shared publications - Peicho Petkov
Sofia University “St. Kliment Ohridski
29 shared publications - Leandar Litov
Sofia University “St. Kliment Ohridski
28 shared publications - Genoveva Nacheva
Institute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
13 shared publications - Elena Krachmarova
Institute of Molecular Biology "Acad. Roumen Tsanev", Bulgarian Academy of Sciences, Sofia, BULGARIA
12 shared publications W. Thirring
University of Vienna, Institute for Theoretical Physics, Boltzmanngasse 5, 1090 Vienna, Austria
9 shared publications
Latest Publications
- 1 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 35 (1)
SARS-CoV-2 NSP8 derived peptide effectively suppresses the activity of helicase NSP13
Highlights: • NSP8-N binds NSP13, occupying residues required for TBK1 and NSP8-NSP13 association. • NSP8-N blocks NSP13-TBK1, occupies RTC, and inhibits immune evasion and replication. • NSP8-N restores the IFN-β expression in cells coexpressing NSP13.
- 1 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 35 (1)
SARS-CoV-2 NSP8 derived peptide effectively suppresses the activity of helicase NSP13
Highlights: • NSP8-N binds NSP13, occupying residues required for TBK1 and NSP8-NSP13 association. • NSP8-N blocks NSP13-TBK1, occupies RTC, and inhibits immune evasion and replication. • NSP8-N restores the IFN-β expression in cells coexpressing NSP13.
- 3 June 2026
- Published by Springer Nature
- p. 368-375
In Silico Analysis of pH Stability of a Trypsin Inhibitor Cyclotide
- 3 June 2026
- Published by Springer Nature
- p. 368-375
In Silico Analysis of pH Stability of a Trypsin Inhibitor Cyclotide
- 3 June 2026
- Published by Springer Nature
- p. 341-349
Metadynamics Study of Charged-Peptides Membrane-Destruction Potential
- 3 June 2026
- Published by Springer Nature
- p. 341-349
Metadynamics Study of Charged-Peptides Membrane-Destruction Potential
- 7 August 2025
- Published by Springer Nature
- p. 109-121
Toy Model of a Multi-component Antimicrobial Substance with Novel Low-Molecular-Weight Snail-Mucus Peptides
- 7 August 2025
- Published by Springer Nature
- p. 109-121
Toy Model of a Multi-component Antimicrobial Substance with Novel Low-Molecular-Weight Snail-Mucus Peptides
- 7 August 2025
- Published by Springer Nature
- p. 185-194
In Silico Screening for Potential Inhibitors of the SARS-CoV-2 Helicase Nsp13
- 7 August 2025
- Published by Springer Nature
- p. 185-194
In Silico Screening for Potential Inhibitors of the SARS-CoV-2 Helicase Nsp13
- Open Access
- 17 July 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 778, 152294
Neutral peptides allow aggregation of cationic peptides in antimicrobial secretory fluids
- 17 July 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 778, 152294
Open AccessNeutral peptides allow aggregation of cationic peptides in antimicrobial secretory fluids
- Open Access
- 25 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9)
Impact of SARS-CoV-2 RBM Mutations N501Y and E484K on ACE2 Binding: A Combined Computational and Experimental Study
The SARS-CoV-2 spike receptor-binding motif is crucial for viral entry via interaction with the human ACE2 receptor. Mutations N501Y and E484K, found in several variants of concern, impact viral transmissibility and immune escape, but experimental data on their binding effects remain inconsistent. Using isothermal titration calorimetry (ITC) and molecular dynamics (MD) simulations, we analyzed the thermodynamic and structural effects of these mutations. ITC confirmed that N501Y increases ACE2 affinity by 2.2-fold, while E484K enhances binding by 5.8-fold. The Beta/Gamma variant (carrying both mutations) showed the strongest affinity, with a 15-fold increase. E484K was enthalpy-driven, while N501Y introduced entropy-driven effects, suggesting hydrophobic interactions and conformational changes. MD simulations revealed distinct binding poses, with Beta/Gamma peptides interacting with a secondary ACE2 site. A strong correlation was found between entropy contributions and hydrophobic contacts. Additionally, a convolutional neural network was used to estimate the free binding energy of these complexes. Our findings confirm that N501Y and E484K enhance ACE2 binding, with the greatest effect when combined, providing insights into SARS-CoV-2 variant evolution and potential therapeutic strategies.
- 25 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9)
Open AccessImpact of SARS-CoV-2 RBM Mutations N501Y and E484K on ACE2 Binding: A Combined Computational and Experimental Study
The SARS-CoV-2 spike receptor-binding motif is crucial for viral entry via interaction with the human ACE2 receptor. Mutations N501Y and E484K, found in several variants of concern, impact viral transmissibility and immune escape, but experimental data on their binding effects remain inconsistent. Using isothermal titration calorimetry (ITC) and molecular dynamics (MD) simulations, we analyzed the thermodynamic and structural effects of these mutations. ITC confirmed that N501Y increases ACE2 affinity by 2.2-fold, while E484K enhances binding by 5.8-fold. The Beta/Gamma variant (carrying both mutations) showed the strongest affinity, with a 15-fold increase. E484K was enthalpy-driven, while N501Y introduced entropy-driven effects, suggesting hydrophobic interactions and conformational changes. MD simulations revealed distinct binding poses, with Beta/Gamma peptides interacting with a secondary ACE2 site. A strong correlation was found between entropy contributions and hydrophobic contacts. Additionally, a convolutional neural network was used to estimate the free binding energy of these complexes. Our findings confirm that N501Y and E484K enhance ACE2 binding, with the greatest effect when combined, providing insights into SARS-CoV-2 variant evolution and potential therapeutic strategies.
- Open Access
- 28 March 2025
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (3) , 348–355
In Silico Analysis of the Interaction of Human Interferon γ C-terminal Peptide and Heparan Sulphate Derived Octasaccharides
Human interferon γ (hIFNγ) is a crucial immunomodulatory cytokine that exerts its effects by binding to a high-affinity receptor complex on the cell surface. In addition to receptor binding, hIFNγ also displays strong affinity for heparin and heparan sulphate, primarily via its C-terminal domain. This interaction influences various physicochemical properties of the cytokine, including its receptor affinity, and could be harnessed for designing hIFNγ inhibitors. Current experimental methods cannot precisely determine sulphate group arrangements in heparin-like and HS-like octasaccharides, which influence charge distribution and potentially affect their binding affinity to the hIFNγ C-terminal peptide. Here, we propose an in silico approach to explore different sulphation patterns in octasaccharides containing one acetyl and seven sulphate groups, aiming to identify those that optimize binding to the hIFNγ C-terminal peptide.
- 28 March 2025
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 78 (3) , 348–355
Open AccessIn Silico Analysis of the Interaction of Human Interferon γ C-terminal Peptide and Heparan Sulphate Derived Octasaccharides
Human interferon γ (hIFNγ) is a crucial immunomodulatory cytokine that exerts its effects by binding to a high-affinity receptor complex on the cell surface. In addition to receptor binding, hIFNγ also displays strong affinity for heparin and heparan sulphate, primarily via its C-terminal domain. This interaction influences various physicochemical properties of the cytokine, including its receptor affinity, and could be harnessed for designing hIFNγ inhibitors. Current experimental methods cannot precisely determine sulphate group arrangements in heparin-like and HS-like octasaccharides, which influence charge distribution and potentially affect their binding affinity to the hIFNγ C-terminal peptide. Here, we propose an in silico approach to explore different sulphation patterns in octasaccharides containing one acetyl and seven sulphate groups, aiming to identify those that optimize binding to the hIFNγ C-terminal peptide.
- Open Access
- 29 February 2024
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 77 (2) , 213–220
Biodynamical Implications of Grafting Position Alteration in Engineered Mimics of Parkinson's Inhibitor MCoCP4
Proteins are currently the fastest-growing class of new therapeutic compounds but smaller proteins and peptides are generally not suitable for use as drugs. Using cyclotides – special knotted proteins stabilized by three pairs of disulphide bonds – as a transport means by grafting onto them as a scaffolding the bioactive peptides can enhance their stability, cellular uptake, and overall efficacy. Experimental methods for creating peptide aptamers are highly time- and resources-consuming. In silico approaches may speed up this process by pre-selecting the drug candidates based on certain biodynamic criteria. In this study, we probe the hypothesis about a relation between the scaffolding conformational stability in conjunction with certain plasticity upon grafting of functionally important domains and the desired biological activity of the modified through the grafting process molecules.
- 29 February 2024
- Published by Prof. Marin Drinov Publishing House of BAS (Bulgarian Academy of Sciences) in Proceedings of the Bulgarian Academy of Sciences
- Vol. 77 (2) , 213–220
Open AccessBiodynamical Implications of Grafting Position Alteration in Engineered Mimics of Parkinson's Inhibitor MCoCP4
Proteins are currently the fastest-growing class of new therapeutic compounds but smaller proteins and peptides are generally not suitable for use as drugs. Using cyclotides – special knotted proteins stabilized by three pairs of disulphide bonds – as a transport means by grafting onto them as a scaffolding the bioactive peptides can enhance their stability, cellular uptake, and overall efficacy. Experimental methods for creating peptide aptamers are highly time- and resources-consuming. In silico approaches may speed up this process by pre-selecting the drug candidates based on certain biodynamic criteria. In this study, we probe the hypothesis about a relation between the scaffolding conformational stability in conjunction with certain plasticity upon grafting of functionally important domains and the desired biological activity of the modified through the grafting process molecules.
- Open Access
- 10 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2155
Interferon-γ as a Potential Inhibitor of SARS-CoV-2 ORF6 Accessory Protein
The ORF6 protein of the SARS-CoV-2 virus plays a crucial role in blocking the innate immune response of the infected cells by inhibiting interferon pathways. Additionally, it binds to and immobilises the RAE1 protein on the cytoplasmic membranes, thereby blocking mRNA transport from the nucleus to the cytoplasm. In all these cases, the host cell proteins are tethered by the flexible C-terminus of ORF6. A possible strategy to inhibit the biological activity of ORF6 is to bind its C-terminus with suitable ligands. Our in silico experiments suggest that hIFN binds the ORF6 protein with high affinity, thus impairing its interactions with RAE1 and, consequently, its activity in viral invasion. The in vitro studies reported here reveal a shift of the localisation of RAE1 in ORF6 overexpressing cells upon treatment with hIFN from predominantly cytoplasmic to mainly nuclear, resulting in the restoration of the export of mRNA from the nucleus. We also explored the expression of GFP in transfected-with-ORF6 cells by means of fluorescence microscopy and qRT-PCR, finding that treatment with hIFN unblocks the mRNA trafficking and reinstates the GFP expression level. The ability of the cytokine to block ORF6 is also reflected in minimising its negative effects on DNA replication by reducing accumulated RNA-DNA hybrids. Our results, therefore, suggest hIFN as a promising inhibitor of the most toxic SARS-CoV-2 protein.- 10 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 2155
Open AccessInterferon-γ as a Potential Inhibitor of SARS-CoV-2 ORF6 Accessory Protein
The ORF6 protein of the SARS-CoV-2 virus plays a crucial role in blocking the innate immune response of the infected cells by inhibiting interferon pathways. Additionally, it binds to and immobilises the RAE1 protein on the cytoplasmic membranes, thereby blocking mRNA transport from the nucleus to the cytoplasm. In all these cases, the host cell proteins are tethered by the flexible C-terminus of ORF6. A possible strategy to inhibit the biological activity of ORF6 is to bind its C-terminus with suitable ligands. Our in silico experiments suggest that hIFN binds the ORF6 protein with high affinity, thus impairing its interactions with RAE1 and, consequently, its activity in viral invasion. The in vitro studies reported here reveal a shift of the localisation of RAE1 in ORF6 overexpressing cells upon treatment with hIFN from predominantly cytoplasmic to mainly nuclear, resulting in the restoration of the export of mRNA from the nucleus. We also explored the expression of GFP in transfected-with-ORF6 cells by means of fluorescence microscopy and qRT-PCR, finding that treatment with hIFN unblocks the mRNA trafficking and reinstates the GFP expression level. The ability of the cytokine to block ORF6 is also reflected in minimising its negative effects on DNA replication by reducing accumulated RNA-DNA hybrids. Our results, therefore, suggest hIFN as a promising inhibitor of the most toxic SARS-CoV-2 protein.